This document discusses two categories of drugs - carminatives and digestants.
Carminatives are drugs that promote the expulsion of gases from the gastrointestinal tract and provide a feeling of warmth and comfort in the epigastrium. Commonly used carminatives include sodium bicarbonate, peppermint oil, cardamom tincture, dill oil, and ginger tincture.
Digestants are substances intended to promote digestion by supplying digestive enzymes. Examples include hydrochloric acid, pepsin, papain, pancreatin, and diastase. They may be beneficial in conditions where enzyme production is deficient but their routine use is generally not recommended. Side effects of digestants can
The document discusses various drugs used to treat peptic ulcers. It begins by describing peptic ulcers and their pathogenesis. It then covers several classes of anti-ulcer drugs that work by reducing acid secretion, such as H2 blockers like cimetidine and proton pump inhibitors like omeprazole. Other drug approaches discussed include agents that enhance mucosal defense like misoprostol, and antacids that neutralize gastric acid. The role of Helicobacter pylori infection in ulcers is also summarized.
This document discusses peptic ulcers, including their causes, symptoms, and treatments. It notes that peptic ulcers are open sores in the upper digestive tract that can form in the stomach (gastric ulcer) or small intestine (duodenal ulcer). Common causes include H. pylori infection, NSAIDs, and stress. Symptoms may include abdominal pain, nausea, black stools, or weight loss. Treatments discussed include antibiotics to kill H. pylori, antacids to neutralize stomach acid, drugs that decrease acid secretion, ulcer protective drugs to coat the ulcer, and ulcer healing drugs.
Asthma is characterized by airway hyperresponsiveness and inflammation. Common symptoms include wheezing, coughing, and shortness of breath. Treatment approaches include preventing antigen exposure, reducing inflammation, blocking mediators, and dilating airways. Main drug classes used are bronchodilators like beta-2 agonists, methylxanthines, anticholinergics; leukotriene antagonists; mast cell stabilizers; inhaled and systemic corticosteroids; and anti-IgE antibodies for severe cases. Medications work by various mechanisms like increasing cAMP, blocking receptors, or inhibiting inflammatory pathways. Choice of treatment depends on severity and goals of management.
This document discusses anti-diarrheal treatments. It introduces that diarrhoea and constipation negatively impact quality of life and health care costs. About 8-9% of people suffer from chronic constipation and 4-5% from chronic diarrhoea. Common causes of diarrhoea include infection, diet, medication, and intestinal disease. Treatment involves rehydration, antimotility agents like loperamide to reduce motility, and antimicrobials for infectious causes. Prevention emphasizes good hygiene and handwashing to avoid spread of infectious diarrhoea.
This document summarizes anti-ulcer drugs. It describes how peptic ulcers develop from an imbalance of aggressive and defensive factors in the stomach. It then classifies and describes different types of anti-ulcer drugs that work by reducing acid secretion, neutralizing acid, protecting the stomach lining, or treating Helicobacter pylori infections. Key drug classes discussed include H2 receptor antagonists like ranitidine and famotidine, proton pump inhibitors like omeprazole, antacids, and anti-H. pylori therapies. Sucralfate and bismuth salts are also covered as ulcer protective agents.
Clinical Symptoms and Management of Morphine ,Organophosphorus and Mercury ...Drx Piyush Lodhi
The document provides information on morphine, organophosphorus, and mercury poisoning. It discusses the symptoms, diagnosis, and treatment of each type of poisoning. For morphine poisoning, it outlines the three stages of symptoms from excitement to coma. Treatment involves gastric lavage and administration of the antidote naloxone. For organophosphorus poisoning, it describes how the chemicals inhibit acetylcholinesterase leading to excess acetylcholine and lists atropine and oxime compounds as antidotes. Mercury poisoning can be elemental, inorganic, or organic with each having different toxic profiles. Diagnosis involves blood and urine mercury levels while chelation therapy with DMPS is the treatment of choice.
This document discusses two categories of drugs - carminatives and digestants.
Carminatives are drugs that promote the expulsion of gases from the gastrointestinal tract and provide a feeling of warmth and comfort in the epigastrium. Commonly used carminatives include sodium bicarbonate, peppermint oil, cardamom tincture, dill oil, and ginger tincture.
Digestants are substances intended to promote digestion by supplying digestive enzymes. Examples include hydrochloric acid, pepsin, papain, pancreatin, and diastase. They may be beneficial in conditions where enzyme production is deficient but their routine use is generally not recommended. Side effects of digestants can
The document discusses various drugs used to treat peptic ulcers. It begins by describing peptic ulcers and their pathogenesis. It then covers several classes of anti-ulcer drugs that work by reducing acid secretion, such as H2 blockers like cimetidine and proton pump inhibitors like omeprazole. Other drug approaches discussed include agents that enhance mucosal defense like misoprostol, and antacids that neutralize gastric acid. The role of Helicobacter pylori infection in ulcers is also summarized.
This document discusses peptic ulcers, including their causes, symptoms, and treatments. It notes that peptic ulcers are open sores in the upper digestive tract that can form in the stomach (gastric ulcer) or small intestine (duodenal ulcer). Common causes include H. pylori infection, NSAIDs, and stress. Symptoms may include abdominal pain, nausea, black stools, or weight loss. Treatments discussed include antibiotics to kill H. pylori, antacids to neutralize stomach acid, drugs that decrease acid secretion, ulcer protective drugs to coat the ulcer, and ulcer healing drugs.
Asthma is characterized by airway hyperresponsiveness and inflammation. Common symptoms include wheezing, coughing, and shortness of breath. Treatment approaches include preventing antigen exposure, reducing inflammation, blocking mediators, and dilating airways. Main drug classes used are bronchodilators like beta-2 agonists, methylxanthines, anticholinergics; leukotriene antagonists; mast cell stabilizers; inhaled and systemic corticosteroids; and anti-IgE antibodies for severe cases. Medications work by various mechanisms like increasing cAMP, blocking receptors, or inhibiting inflammatory pathways. Choice of treatment depends on severity and goals of management.
This document discusses anti-diarrheal treatments. It introduces that diarrhoea and constipation negatively impact quality of life and health care costs. About 8-9% of people suffer from chronic constipation and 4-5% from chronic diarrhoea. Common causes of diarrhoea include infection, diet, medication, and intestinal disease. Treatment involves rehydration, antimotility agents like loperamide to reduce motility, and antimicrobials for infectious causes. Prevention emphasizes good hygiene and handwashing to avoid spread of infectious diarrhoea.
This document summarizes anti-ulcer drugs. It describes how peptic ulcers develop from an imbalance of aggressive and defensive factors in the stomach. It then classifies and describes different types of anti-ulcer drugs that work by reducing acid secretion, neutralizing acid, protecting the stomach lining, or treating Helicobacter pylori infections. Key drug classes discussed include H2 receptor antagonists like ranitidine and famotidine, proton pump inhibitors like omeprazole, antacids, and anti-H. pylori therapies. Sucralfate and bismuth salts are also covered as ulcer protective agents.
Clinical Symptoms and Management of Morphine ,Organophosphorus and Mercury ...Drx Piyush Lodhi
The document provides information on morphine, organophosphorus, and mercury poisoning. It discusses the symptoms, diagnosis, and treatment of each type of poisoning. For morphine poisoning, it outlines the three stages of symptoms from excitement to coma. Treatment involves gastric lavage and administration of the antidote naloxone. For organophosphorus poisoning, it describes how the chemicals inhibit acetylcholinesterase leading to excess acetylcholine and lists atropine and oxime compounds as antidotes. Mercury poisoning can be elemental, inorganic, or organic with each having different toxic profiles. Diagnosis involves blood and urine mercury levels while chelation therapy with DMPS is the treatment of choice.
This document discusses appetite suppressants, carminatives, and digestants. It describes how appetite is regulated by factors like energy expenditure, absorption, and hormones. Obesity results from an imbalance where energy intake exceeds expenditure due to genetic, environmental, neurological, and dietary factors. Several classes of appetite suppressants are listed that work through different mechanisms in the body. Carminatives like sodium bicarbonate, peppermint oil, and ginger help expel gas from the gastrointestinal tract. Digestants contain enzymes to aid digestion and are sometimes used when enzyme production is deficient, though their general use as tonics is irrational. Specific digestive enzymes, their sources, and appropriate uses are outlined.
This document discusses drugs used as digestants and carminatives. Digestants are substances that promote digestion by containing enzymes like pepsin, papain, pancreatin, and diastase. They are occasionally beneficial for people with deficient enzyme production, but their routine use is irrational. Carminatives are agents that promote the expulsion of gases from the gastrointestinal tract and provide a feeling of warmth. Common carminatives include sodium bicarbonate, peppermint oil, cardamom oil, dill oil, and ginger tincture. These drugs are used to treat dyspepsia, discomfort in the upper abdomen, gas formation, and feelings of fullness or burning.
Urinary tract infections are mainly caused by bacteria like E. coli and Staphylococcus. Common symptoms include burning during urination and red or pink colored urine. Quinolones are a class of antibiotics that are highly effective against many infectious diseases, including those caused by bacteria in the urinary tract. Quinolones work by inhibiting the bacterial DNA gyrase enzyme, which is responsible for compacting DNA and allowing replication. Some examples of quinolones used to treat UTIs are ciprofloxacin, norfloxacin, and ofloxacin. Other classes of antibiotics that can be used to treat UTIs include nitrofurans, sulfa drugs, and methenamine.
Sulphonamides are among the oldest antibacterial agents used to treat infections. They work by competitively inhibiting the enzyme dihydropteroate synthase, blocking folic acid synthesis in bacteria. This makes them bacteriostatic rather than bactericidal. Chemical modifications of the sulphonamide structure have led to important drug classes like diuretics, hypoglycemics, and anti-mycobacterials. Sulphonamides are commonly used to treat urinary tract, respiratory, and other bacterial infections. When combined with trimethoprim, they have broad-spectrum activity against many pathogens and are used as co-trimoxazole. Adverse effects can include allergic reactions and bone marrow suppression.
This document discusses different classes of antidiabetic drugs used to treat diabetes mellitus. It describes how these drugs work to lower blood glucose levels by different mechanisms such as increasing insulin secretion from the pancreas, increasing insulin sensitivity, or decreasing glucose absorption. The main classes covered are sulfonylureas, meglitinides, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, and SGLT-2 inhibitors. Specific drugs discussed in more detail include tolbutamide, metformin, and glipizide.
This document discusses drugs used to treat amoebiasis, an infection caused by Entamoeba histolytica. It describes the life cycle and stages of E. histolytica, as well as the different types of amoebiasis. The main drugs discussed are metronidazole, tinidazole, emetine, diloxanide furoate, chloroquine, and paromomycin. It provides details on the mechanisms of action, pharmacokinetics, uses, and side effects of these various anti-amoebic drugs.
The document discusses anti-ulcer drugs. It begins by describing peptic ulcers and the imbalance between aggressive and defensive factors that can lead to their development. It then covers the classes of anti-ulcer drugs, including H2 blockers that reduce acid secretion, proton pump inhibitors, prostaglandin analogs, and antacids. Sucralfate and colloidal bismuth subcitrate are also covered as ulcer protective drugs. Diagnostic tests for ulcers like endoscopy and barium meal are mentioned. The goal of anti-ulcer treatment is outlined as relieving pain, promoting healing, preventing complications, and reducing relapse.
this will give brief about the peptic ulcer and give information about the drug used for peptic ulcer and classification of drugs including drugs and there use adverse effect.
The document discusses barbiturate and morphine/opioid poisoning. It provides details on the classification, mechanism of action, signs and symptoms, and management of barbiturate poisoning. It describes how barbiturates bind to GABA receptors and prolong opening of chloride channels, inhibiting the central nervous system. Signs of acute poisoning include depression, amnesia, respiratory issues and death from respiratory arrest. Management involves cardio-respiratory support, preventing drug absorption, and removing barbiturates from the body through charcoal, diuresis or dialysis. For morphine/opioid poisoning, it notes respiratory depression as a major risk and describes treatment with naloxone to reverse effects or intubation to ensure
This document discusses anti-asthmatic drugs, including their classification, mechanisms of action, routes of administration, and examples. It begins by defining anti-asthmatic drugs as medicines that treat or prevent asthma attacks by opening up airways. It then classifies these drugs based on their mechanism of action (bronchodilation or anti-inflammatory) and route of administration (oral, inhaled, etc.). The document provides examples of different drug classes, their advantages and disadvantages, and precautions for specific drugs. It concludes with monitoring advice for certain anti-asthmatic medications.
immunostimulants and immunosupprasants.pptxSaurabh Gupta
Immunostimulants are substances that stimulate the immune system to fight infections and diseases. They can be specific, providing immunity to particular antigens through vaccines, or non-specific by generally enhancing immune responses through substances like immunoglobulins, thalidomide, interferons, or immunocynin. Immunostimulants are useful for treating infections, cancers, and immunodeficiencies. In contrast, immunosuppressants are drugs that inhibit immune responses and are used to prevent organ transplant rejection and treat autoimmune disorders. Common side effects of immunosuppressants include infection, headaches, stomach upset, and weight gain.
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
This document summarizes anti-diarrheal and constipation drugs. It defines diarrhea and constipation and discusses common causes of diarrhea like viruses, alcohol, food allergies, and bacteria. It describes different classes of anti-diarrheal drugs like anti-motility drugs that decrease bowel motility, anticholinergics, and anti-infectives. It also outlines classes of drugs used to treat constipation like bulk forming agents, osmotic agents, stool softeners, and stimulant purgatives. The mechanisms of action for some anti-diarrheal and laxative drugs are also briefly explained.
Certain drugs, hormones, and compounds can increase appetite and induce hyperphagia by acting on hunger hormones like ghrelin, neuropeptide Y, and orexin. While appetite enhancement can be an undesirable side effect of some medications, these appetite-stimulating substances can benefit patients with severe appetite loss or muscle wasting. Common classes of drugs that increase hunger include antidepressants, antipsychotics, antihistamines, and medications that block serotonin, adrenaline, dopamine, or corticosteroid receptors. However, some appetite-stimulating drugs like fenfluramine and sibutramine were banned due to safety issues like heart valve problems and increased risk of heart attacks.
1) Peptic ulcers are caused by an imbalance between aggressive factors like gastric acid and protective factors in the stomach and duodenum.
2) Anti-ulcer drugs work by decreasing gastric acid secretion, enhancing mucosal protection, or eradicating the H. pylori bacteria responsible for many ulcers.
3) Common classes of anti-ulcer medications include H2 receptor antagonists, proton pump inhibitors, antacids, and anti-H. pylori drugs. H2 receptor antagonists and proton pump inhibitors reduce acid by blocking histamine and the proton pump, while antacids neutralize existing acid.
This document discusses the synthesis, mechanisms, properties, and uses of several antifungal drugs: Metronidazole, Ketoconazole, Terconazole, and Miconazole. It provides details on the synthesis routes for each drug involving reactions of intermediates. The mechanisms of action involve inhibiting enzymes necessary for fungal cell wall synthesis or metabolism, which damages DNA and leads to cell death. The properties described include melting points, solubility, and physical forms. All four drugs are used as broad-spectrum antifungal agents to treat various fungal infections.
This document discusses pharmacotherapy for peptic ulcer disease. It outlines the physiology of gastric acid secretion stimulated by various phases. Peptic ulcer disease is defined as an erosion of the gastrointestinal tract exposed to acid and pepsin. Causes include Helicobacter pylori, NSAIDs, alcohol, stress, and steroids. Therapies aim to enhance defenses or eliminate aggressive factors like H. pylori. Drug classes discussed are antacids, H2 receptor antagonists, prostaglandin analogues, and antibiotics for H. pylori.
The document discusses drugs used to treat peptic ulcers. It explains that peptic ulcers result from an imbalance between acid-pepsin secretion and mucosal defenses in the gastrointestinal tract. Various classes of drugs are described that work by neutralizing acid, reducing acid secretion, or protecting the mucosa. Antacids neutralize acid but do not reduce secretion. H2 receptor blockers and proton pump inhibitors competitively inhibit acid secretion through different mechanisms. Protective drugs like sucralfate coat the mucosa to prevent damage from acid.
This document discusses appetite suppressants, carminatives, and digestants. It describes how appetite is regulated by factors like energy expenditure, absorption, and hormones. Obesity results from an imbalance where energy intake exceeds expenditure due to genetic, environmental, neurological, and dietary factors. Several classes of appetite suppressants are listed that work through different mechanisms in the body. Carminatives like sodium bicarbonate, peppermint oil, and ginger help expel gas from the gastrointestinal tract. Digestants contain enzymes to aid digestion and are sometimes used when enzyme production is deficient, though their general use as tonics is irrational. Specific digestive enzymes, their sources, and appropriate uses are outlined.
This document discusses drugs used as digestants and carminatives. Digestants are substances that promote digestion by containing enzymes like pepsin, papain, pancreatin, and diastase. They are occasionally beneficial for people with deficient enzyme production, but their routine use is irrational. Carminatives are agents that promote the expulsion of gases from the gastrointestinal tract and provide a feeling of warmth. Common carminatives include sodium bicarbonate, peppermint oil, cardamom oil, dill oil, and ginger tincture. These drugs are used to treat dyspepsia, discomfort in the upper abdomen, gas formation, and feelings of fullness or burning.
Urinary tract infections are mainly caused by bacteria like E. coli and Staphylococcus. Common symptoms include burning during urination and red or pink colored urine. Quinolones are a class of antibiotics that are highly effective against many infectious diseases, including those caused by bacteria in the urinary tract. Quinolones work by inhibiting the bacterial DNA gyrase enzyme, which is responsible for compacting DNA and allowing replication. Some examples of quinolones used to treat UTIs are ciprofloxacin, norfloxacin, and ofloxacin. Other classes of antibiotics that can be used to treat UTIs include nitrofurans, sulfa drugs, and methenamine.
Sulphonamides are among the oldest antibacterial agents used to treat infections. They work by competitively inhibiting the enzyme dihydropteroate synthase, blocking folic acid synthesis in bacteria. This makes them bacteriostatic rather than bactericidal. Chemical modifications of the sulphonamide structure have led to important drug classes like diuretics, hypoglycemics, and anti-mycobacterials. Sulphonamides are commonly used to treat urinary tract, respiratory, and other bacterial infections. When combined with trimethoprim, they have broad-spectrum activity against many pathogens and are used as co-trimoxazole. Adverse effects can include allergic reactions and bone marrow suppression.
This document discusses different classes of antidiabetic drugs used to treat diabetes mellitus. It describes how these drugs work to lower blood glucose levels by different mechanisms such as increasing insulin secretion from the pancreas, increasing insulin sensitivity, or decreasing glucose absorption. The main classes covered are sulfonylureas, meglitinides, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, and SGLT-2 inhibitors. Specific drugs discussed in more detail include tolbutamide, metformin, and glipizide.
This document discusses drugs used to treat amoebiasis, an infection caused by Entamoeba histolytica. It describes the life cycle and stages of E. histolytica, as well as the different types of amoebiasis. The main drugs discussed are metronidazole, tinidazole, emetine, diloxanide furoate, chloroquine, and paromomycin. It provides details on the mechanisms of action, pharmacokinetics, uses, and side effects of these various anti-amoebic drugs.
The document discusses anti-ulcer drugs. It begins by describing peptic ulcers and the imbalance between aggressive and defensive factors that can lead to their development. It then covers the classes of anti-ulcer drugs, including H2 blockers that reduce acid secretion, proton pump inhibitors, prostaglandin analogs, and antacids. Sucralfate and colloidal bismuth subcitrate are also covered as ulcer protective drugs. Diagnostic tests for ulcers like endoscopy and barium meal are mentioned. The goal of anti-ulcer treatment is outlined as relieving pain, promoting healing, preventing complications, and reducing relapse.
this will give brief about the peptic ulcer and give information about the drug used for peptic ulcer and classification of drugs including drugs and there use adverse effect.
The document discusses barbiturate and morphine/opioid poisoning. It provides details on the classification, mechanism of action, signs and symptoms, and management of barbiturate poisoning. It describes how barbiturates bind to GABA receptors and prolong opening of chloride channels, inhibiting the central nervous system. Signs of acute poisoning include depression, amnesia, respiratory issues and death from respiratory arrest. Management involves cardio-respiratory support, preventing drug absorption, and removing barbiturates from the body through charcoal, diuresis or dialysis. For morphine/opioid poisoning, it notes respiratory depression as a major risk and describes treatment with naloxone to reverse effects or intubation to ensure
This document discusses anti-asthmatic drugs, including their classification, mechanisms of action, routes of administration, and examples. It begins by defining anti-asthmatic drugs as medicines that treat or prevent asthma attacks by opening up airways. It then classifies these drugs based on their mechanism of action (bronchodilation or anti-inflammatory) and route of administration (oral, inhaled, etc.). The document provides examples of different drug classes, their advantages and disadvantages, and precautions for specific drugs. It concludes with monitoring advice for certain anti-asthmatic medications.
immunostimulants and immunosupprasants.pptxSaurabh Gupta
Immunostimulants are substances that stimulate the immune system to fight infections and diseases. They can be specific, providing immunity to particular antigens through vaccines, or non-specific by generally enhancing immune responses through substances like immunoglobulins, thalidomide, interferons, or immunocynin. Immunostimulants are useful for treating infections, cancers, and immunodeficiencies. In contrast, immunosuppressants are drugs that inhibit immune responses and are used to prevent organ transplant rejection and treat autoimmune disorders. Common side effects of immunosuppressants include infection, headaches, stomach upset, and weight gain.
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
This document summarizes anti-diarrheal and constipation drugs. It defines diarrhea and constipation and discusses common causes of diarrhea like viruses, alcohol, food allergies, and bacteria. It describes different classes of anti-diarrheal drugs like anti-motility drugs that decrease bowel motility, anticholinergics, and anti-infectives. It also outlines classes of drugs used to treat constipation like bulk forming agents, osmotic agents, stool softeners, and stimulant purgatives. The mechanisms of action for some anti-diarrheal and laxative drugs are also briefly explained.
Certain drugs, hormones, and compounds can increase appetite and induce hyperphagia by acting on hunger hormones like ghrelin, neuropeptide Y, and orexin. While appetite enhancement can be an undesirable side effect of some medications, these appetite-stimulating substances can benefit patients with severe appetite loss or muscle wasting. Common classes of drugs that increase hunger include antidepressants, antipsychotics, antihistamines, and medications that block serotonin, adrenaline, dopamine, or corticosteroid receptors. However, some appetite-stimulating drugs like fenfluramine and sibutramine were banned due to safety issues like heart valve problems and increased risk of heart attacks.
1) Peptic ulcers are caused by an imbalance between aggressive factors like gastric acid and protective factors in the stomach and duodenum.
2) Anti-ulcer drugs work by decreasing gastric acid secretion, enhancing mucosal protection, or eradicating the H. pylori bacteria responsible for many ulcers.
3) Common classes of anti-ulcer medications include H2 receptor antagonists, proton pump inhibitors, antacids, and anti-H. pylori drugs. H2 receptor antagonists and proton pump inhibitors reduce acid by blocking histamine and the proton pump, while antacids neutralize existing acid.
This document discusses the synthesis, mechanisms, properties, and uses of several antifungal drugs: Metronidazole, Ketoconazole, Terconazole, and Miconazole. It provides details on the synthesis routes for each drug involving reactions of intermediates. The mechanisms of action involve inhibiting enzymes necessary for fungal cell wall synthesis or metabolism, which damages DNA and leads to cell death. The properties described include melting points, solubility, and physical forms. All four drugs are used as broad-spectrum antifungal agents to treat various fungal infections.
This document discusses pharmacotherapy for peptic ulcer disease. It outlines the physiology of gastric acid secretion stimulated by various phases. Peptic ulcer disease is defined as an erosion of the gastrointestinal tract exposed to acid and pepsin. Causes include Helicobacter pylori, NSAIDs, alcohol, stress, and steroids. Therapies aim to enhance defenses or eliminate aggressive factors like H. pylori. Drug classes discussed are antacids, H2 receptor antagonists, prostaglandin analogues, and antibiotics for H. pylori.
The document discusses drugs used to treat peptic ulcers. It explains that peptic ulcers result from an imbalance between acid-pepsin secretion and mucosal defenses in the gastrointestinal tract. Various classes of drugs are described that work by neutralizing acid, reducing acid secretion, or protecting the mucosa. Antacids neutralize acid but do not reduce secretion. H2 receptor blockers and proton pump inhibitors competitively inhibit acid secretion through different mechanisms. Protective drugs like sucralfate coat the mucosa to prevent damage from acid.
This document discusses various drugs used to treat gastrointestinal conditions. It covers drugs that act on the gastrointestinal tract like antacids, H2 receptor blockers, proton pump inhibitors, cytoprotectants, antidiarrheals, and antibiotics for H. pylori eradication. It discusses their mechanisms of action, uses, and side effects. Laxatives are also covered, with classifications and mechanisms of different types.
This document summarizes peptic ulcer disease. It begins by defining peptic ulcers as lesions in the stomach or duodenum caused by gastric acid and pepsin. Risk factors for peptic ulcers include an imbalance between aggressive factors like acid and protective mucosal defenses. Common symptoms are epigastric pain and weight loss. Treatment approaches aim to reduce acid secretion through H2 blockers, proton pump inhibitors, anticholinergics, and prostaglandin analogues. Other treatments include antacids to neutralize acid, ulcer protectives like sucralfate, and anti-H. pylori drugs to eradicate H. pylori infections which are a major cause of peptic ul
This document provides information about various types of anti-ulcer drugs, including their mechanisms of action and effects. It discusses anti-pyloric drugs/antibiotics that treat ulcers caused by H. pylori and C. pylori bacteria. It also describes antacids that neutralize stomach acid, drugs that decrease stomach acid secretion like H2 receptor blockers and proton pump inhibitors, and ulcer protective drugs like sucralfate and colloidal bismuth that coat and protect ulcer bases. Finally, it mentions ulcer healing drugs that stimulate mucus secretion to increase gastric mucosal protection and healing.
This document discusses the pathophysiology and treatment of peptic ulcers. It begins by describing the physiology of gastric acid secretion and the roles of histamine, gastrin, and acetylcholine. It then covers various drug classes that reduce acid secretion, including H2 blockers like cimetidine and ranitidine, and proton pump inhibitors like omeprazole. It also discusses antacids, mucosal protectives, and anti-H. pylori regimens. Key treatment strategies include reducing acid with proton pump inhibitors, neutralizing acid with antacids, protecting the mucosa with drugs like sucralfate, and eradicating H. pylori with triple therapy combinations
Both duodenal and gastric ulcer diseases are closely associated with Helicobacter pylori infection. An infected individual has an estimated lifetime risk of 10 -20% for the development of peptic ulcer disease, which is at least 3-4 fold higher than in non-infected subjects. Many drugs are being used as inhibitors of acid secretion and antacids are also effectively used. New potential drugs are also developed and introduced for acid related disease. Combination therapy like triple and quadruple therapy more effective for removal of Helicobacter pylori. Homeopathy and Ayurvedic therapy are also consider as treatment of ulcer. Role of surgery can be option for the bleeding ulcer or ant severe case.
The document discusses various drugs that affect the gastrointestinal system. It reviews drugs that affect GI secretions like histamine H2 receptor blockers, antacids, proton pump inhibitors, mucosal protectants, and prostaglandin analogs. It then focuses on H2 blockers, antacids, proton pump inhibitors, the mucosal protectant sucralfate, and the prostaglandin analog misoprostol, describing their mechanisms of action, clinical uses, precautions, side effects, and drug interactions. The document also briefly mentions the therapeutic indications of laxatives.
This document discusses anti-ulcer agents. It defines peptic ulcers as erosions in the stomach or duodenum lining caused by an imbalance between aggressive factors like acid and protective factors. Common causes of ulcers include H. pylori, NSAIDs, and stress. Treatment approaches aim to reduce acid secretion using H2 blockers, proton pump inhibitors, anticholinergics, and prostaglandins. Other approaches neutralize acid with antacids, protect the ulcer with sucralfate or bismuth, and eradicate H. pylori with antibiotic combinations.
This document provides an overview of peptic ulcer disease. It defines peptic ulcers and discusses their main causes including Helicobacter pylori infection, NSAID use, and Zollinger-Ellison syndrome. It then describes the mechanisms of gastric acid secretion and the goals of antiulcer treatment. Several classes of drugs are covered including those that reduce acid secretion like H2 blockers and proton pump inhibitors, antacids that neutralize acid, and treatments for H. pylori infection. Key learning objectives are outlined for understanding peptic ulcer disease and its pharmacologic management.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
This document discusses drugs that affect gastrointestinal functions, focusing on treatments for peptic ulcers and antiemetic drugs. It describes how peptic ulcers form and are treated using proton pump inhibitors, H2 receptor antagonists, antimicrobials against Helicobacter pylori, and mucosal protective drugs. It also outlines the pathways involved in vomiting and discusses major classes of antiemetic drugs that act on 5-HT3, NK1, D2, H1, and M receptors in the chemoreceptor trigger zone to treat nausea and vomiting from different causes.
This document discusses drugs used to treat peptic ulcers and gastroesophageal reflux disease (GERD). It describes the mechanisms and uses of various classes of drugs including antacids, H2 receptor antagonists, proton pump inhibitors, mucosal protective drugs, and anti-Helicobacter pylori drugs. The main goals of antiulcer therapy are relief from pain, promotion of ulcer healing, prevention of complications and relapse. Proton pump inhibitors are now the most widely used drugs for peptic ulcers due to their strong acid suppression and excellent safety profile. Eradication of H. pylori infection is also important for ulcer treatment and prevention.
Peptic ulcer is caused by an imbalance between aggressive and protective factors in the stomach and duodenum. Key contributing factors include H. pylori infection, NSAID use, smoking, stress, and alcohol consumption. Treatment involves acid-suppressing drugs like antacids, H2 receptor antagonists, proton pump inhibitors, and prostaglandin analogues. Antacids provide fast relief but have short duration, while proton pump inhibitors more effectively reduce acid production for longer periods.
The document discusses drugs used in the gastrointestinal system. It covers drugs used to treat peptic ulcers such as antacids, H2 receptor blockers, and proton pump inhibitors. It also discusses ulcer protectives like sucralfate and bismuth. For constipation and diarrhea, it describes purgatives that work through different mechanisms to induce bowel movements as well as drugs to treat diarrhea like loperamide. Emetics that induce vomiting and various classes of antiemetics are also outlined.
This document discusses drugs used to treat gastrointestinal tract disorders. It focuses on drugs for peptic ulcer disease, including proton pump inhibitors which irreversibly block acid production, and H2 receptor antagonists which reversibly compete with histamine. Proton pump inhibitors are more potent but H2 receptor antagonists adequately suppress nocturnal acid secretion. Cytoprotective drugs like misoprostol and sucralfate are also used. The document provides details on the physiology of acid secretion, mechanisms of action, pharmacokinetics, uses and side effects of these drug classes.
This document discusses the pharmacotherapy of peptic ulcer disease. It begins by describing the physiology of gastric acid secretion and the factors that regulate it. It then discusses peptic ulcer disease itself, including its epidemiology, symptoms, and pathophysiology. The main part of the document covers the various drugs used to treat peptic ulcers, including proton pump inhibitors, H2 receptor antagonists, prostaglandin analogues, anticholinergics, antacids, and ulcer protectives. It also discusses antimicrobial drugs for H. pylori eradication, commonly used combination therapies, and treatments for resistant H. pylori infections.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
The debris of the ‘last major merger’ is dynamically youngSérgio Sacani
The Milky Way’s (MW) inner stellar halo contains an [Fe/H]-rich component with highly eccentric orbits, often referred to as the
‘last major merger.’ Hypotheses for the origin of this component include Gaia-Sausage/Enceladus (GSE), where the progenitor
collided with the MW proto-disc 8–11 Gyr ago, and the Virgo Radial Merger (VRM), where the progenitor collided with the
MW disc within the last 3 Gyr. These two scenarios make different predictions about observable structure in local phase space,
because the morphology of debris depends on how long it has had to phase mix. The recently identified phase-space folds in Gaia
DR3 have positive caustic velocities, making them fundamentally different than the phase-mixed chevrons found in simulations
at late times. Roughly 20 per cent of the stars in the prograde local stellar halo are associated with the observed caustics. Based
on a simple phase-mixing model, the observed number of caustics are consistent with a merger that occurred 1–2 Gyr ago.
We also compare the observed phase-space distribution to FIRE-2 Latte simulations of GSE-like mergers, using a quantitative
measurement of phase mixing (2D causticality). The observed local phase-space distribution best matches the simulated data
1–2 Gyr after collision, and certainly not later than 3 Gyr. This is further evidence that the progenitor of the ‘last major merger’
did not collide with the MW proto-disc at early times, as is thought for the GSE, but instead collided with the MW disc within
the last few Gyr, consistent with the body of work surrounding the VRM.
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
1. PRESENTED BY:
PRASHANT N. AMALE
M.PHARM (PHARMACOLOGY)
DEPARTMENT OF PHARMACEUTICAL SCIENCES
RTMNU,NAGPUR
2.
3. Ulcers are the disorders of the GIT resulting due
to imbalance between factors associated with
protection of mucosa & factors modifying acid
secretion.
Commonest forms of ulcers are:
a. Duodenal ulcers
b. Gastric ulcers
c. Stress induced ulcers
d. NSAID induced ulcers
13. 1. Mucus : Secreted by mucous neck cells.
2. Bicarbonate ions : Secreted by mucous neck cells.
Both Mucus & Bicarbonate form gel like protective
barrier for mucosa.
3. Prostaglandins(PGE2) :Stimulate release of mucus
& bicarbonate ions.
14. 4. Mucosal blood flow : Removes acid that might
diffuse through mucosa.
5. Competent pyloric sphincter : Prevents
regurgitation of aggressive factors ( pancreatic
enzymes) into stomach.
21. PROTON PUMP INHIBITORS
• Most effective drugs in antiulcer therapy
• Irreversible inhibitor of H+ K+ ATPase
• Prodrugs requiring activation in acid environment
• Weakly basic drugs & so accumulate in canaliculi of
parietal cell
• Activated in canaliculi & binds covalently to
extracellular domain of H+ K+ ATPase
• Acid secretion resumes only after synthesis of new
molecules
22. POTON PUMP INHIBITORS – KINETICS
• Given as enteric coated granules in capsule or
enteric coated tablets
• Pantoprazole also given intravenously
• Half life – 1.5 hrs
• Since it requires acid for activation - given 1 hr
before meals
• Other acid suppressing agents not co-
administered
23. P.P.I. – SIDE EFFECTS & INTERACTIONS
• Extremely safe drugs
• Causes hypergastrinemia which leads to
carcinod tumor in rats
• But no evidence of such tumors in man
• Inhibit CYP 450 & hence metabolsim of
warfarin, phenytoin, etc
• Pantoprazole & Rabeprazole have no
significant interactions
24. MISOPROSTOL
• PGE1 analogue
• Modest acid inhibition
• Stimulate mucus & bicarbonate secretion
• Enhance mucuosal blood flow
• Approved for prevention of NSAID induced ulcer
• Diarrhoea & cramping abdominal pain – 20 %
• Not so popular as P.P.I are more effective & better
tolerated
25. ANTACIDS
• Weak bases that neutralise acid
• Also inhibit formation of pepsin
(As pepsinogen converted to pepsin at acidic pH)
• Present day antacids :
Aluminium Hydroxide
Magnesium Hydroxide
• Not part of Physician prescribed regimen
• OTC drug for symptomatic relief of dyspepsia
26. ANTACIDS – CONT…
• Duration of action :
• 30 min when taken in empty stomach
2 hrs when taken after a meal
Side effects :
• Al3+ antacids – constipation (As they relax gastric
smooth muscle & delay gastric emptying)
• Mg2+ antacids – Osmotic diarrhoea .
• In renal failure Al3+ antacid – Aluminium toxicity
&
Encephalopathy
27. ANTACID - INTERACTIONS
• Antacid(CaCo3) with tetracycline form insoluble complexes
that are not absorb .
• Clinical importance :
Interactions can be avoided by taking antacids 2 hrs
before or after ingestion of other drugs .
28. ANSWER THIS QUESTION
• Is it rational to combine aluminium hydroxide and
magnesium hydroxide in antacid preparations ?
29. Answer
• Combination provides a relatively fast and sustained
neutralising capacity .
(Magnesium Hydroxide – Rapidly acting
Aluminium Hydroxide - Slowly acting )
• Combination preserves normal bowel function.
(Aluminium Hydroxide – constipation
Magnesium hydroxide – diarrhoea )
31. SUCRALFATE
• Salt of sucrose complexed to sulfated aluminium
hydroxide
• In acidic pH polymerises to viscous gel that adheres
to ulcer crater
• Taken on empty stomach 1 hr. before meals
• Concurrent antacids, H2 antagonist avoided
(as it needs acid for activation )
32. COLLOIDAL BISMUTH COMPOUNDS
• Coats ulcer, stimulates mucus & bicarbonate secretion
• Direct antimicrobial activity against H.pylori
• May cause blackening of stools & tongue
• Not used for long periods – bismuth toxicity
AVAILABLE COMPOUNDS :
Bismuth subsalicylate – in USA
Bismuth sobcitrate – in Europe
Bismuth dinitrate
33. CARBINOXOLONE :Mechanism
1. Acts on Microsomal glycosyl transferase
2. Inhibits NAM containing mucoprotein
3. Increase mucus secretion,